Solid Biosciences Inc [SLDB] stock prices are down -2.58% to $5.66 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SLDB shares have gain 6.59% over the last week, with a monthly amount drifted -0.88%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Solid Biosciences Inc [NASDAQ: SLDB] stock has seen the most recent analyst activity on December 04, 2025, when Needham initiated its Buy rating and assigned the stock a price target of $16. Previously, Citigroup started tracking the stock with Buy rating on June 26, 2025, and set its price target to $14. On January 08, 2025, Truist initiated with a Buy rating and assigned a price target of $16 on the stock. Wedbush started tracking the stock assigning a Outperform rating and suggested a price target of $16 on December 13, 2024. JMP Securities initiated its recommendation with a Mkt Outperform and recommended $15 as its price target on December 10, 2024. JP Morgan upgraded its rating to Overweight for this stock on July 15, 2024, and upped its price target to $15. In a note dated June 24, 2024, Leerink Partners upgraded an Outperform rating on this stock but restated the target price of $12.
The stock price of Solid Biosciences Inc [SLDB] has been fluctuating between $2.41 and $7.37 over the past year. Currently, Wall Street analysts expect the stock to reach $13.67 within the next 12 months. Solid Biosciences Inc [NASDAQ: SLDB] shares were valued at $5.66 at the most recent close of the market. An investor can expect a potential return of 141.52% based on the average SLDB price forecast.
Analyzing the SLDB fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.61, Equity is -0.74 and Total Capital is -0.71. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Solid Biosciences Inc [NASDAQ:SLDB]’s Current Ratio is 6.74. As well, the Quick Ratio is 6.74, while the Cash Ratio is 1.69.
Transactions by insiders
Recent insider trading involved Tan Kevin, CFO & Treasurer, that happened on Jan 13 ’26 when 5704.0 shares were sold. Officer, Tan Kevin completed a deal on Jan 13 ’26 to buy 5704.0 shares. Meanwhile, Director Ganot Ilan sold 1053.0 shares on Jan 05 ’26.
